This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Deep Brain Stimulation Clinic Expedites Patient Treatment At Muhammad Ali Parkinson Center

PHOENIX, Feb. 20, 2013 /PRNewswire/ -- The Muhammad Ali Parkinson Center in Phoenix has launched a new clinic aimed at streamlining the process for the growing number of patients who are potential candidates for Deep Brain Stimulation.

Deep Brain Stimulation (DBS) is a surgical treatment involving the implantation of a medical device called a "brain pacemaker," which sends electrical impulses to specific parts of the brain. DBS in select brain regions has provided remarkable therapeutic benefits for otherwise treatment-resistant movement and affective disorders such as Parkinson's disease, tremor and dystonia.

The new clinic, which is part of the Ali center at the Barrow Neurological Institute, offers patients a comprehensive resource for education, medical evaluation, psychological assessment, imaging, surgery and post surgical monitoring. The one-day a week clinic was launched in July to serve the increasing numbers of patients who travel from all over the nation for DBS evaluation and surgery.

"We have dramatically reduced the waiting and evaluation time for patients," says Rohit Dhall, MD, who heads the clinic. "In the past, waiting for evaluation and approval for this treatment could be frustrating for patients. So, we have added new resources to the Ali center and established this clinic. It has already become very popular with people from all over Arizona, and as far away as Illinois, Wyoming and Michigan."

Phoenix real estate and development broker Tommy Zuleger is a patient and fan of the new clinic. "The Ali clinic's process was very efficient," says Zuleger. "The best part of the process was having every physician who was involved in my case working together and talking often about my treatment. I know that DBS isn't a cure, but I feel better than I have in years and I hope that it will help to control my symptoms for years to come."

Dr. Dhall emphasizes that DBS is not an effective treatment for all patients. He says previously a patient could wait up to year to complete the evaluation process. Now, the wait time is four to six weeks. Barrow is a leader in the use of DBS to treat movement disorders. Neurosurgeons and neurologists at Barrow were involved in early clinical trials of the therapy and thus have deep experience that is hard to find in the emerging field.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,596.35 -350.33 -1.95%
S&P 500 2,057.64 -43.85 -2.09%
NASDAQ 4,958.4680 -122.0370 -2.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs